Medication info
Telapine Tablet 40/5 mg

Telapine Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Austin Pharmaceutical Co., Ltd.
Appearance
White and light blue, double convex oval-shaped tablet
Packaging
30 tablets/box [10 tablets/strip × 3]
Approval status
Active

MFDS item code 202000463 · Approved 2020.01.29 · Insurance code 654305330

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: Administration of this medicine is not recommended in pediatric patients aged 18 years and younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Austin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Primary hypertension
View approved original text

This medication is useful for patients with primary hypertension whose blood pressure is not well controlled by monotherapy with telmisartan or amlodipine. It is effective in lowering blood pressure and is used to improve hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: Administration of this medicine is not recommended in pediatric patients aged 18 years and younger because its safety and efficacy have not been established.

Precautions

This medication can pose serious risks to the fetus or newborn, particularly during the second and third trimesters of pregnancy, and should not be used by pregnant women or women who may become pregnant. Patients with an allergy to the active ingredients or serious conditions such as certain liver or heart diseases, severe hypotension, heart failure, etc., should not take this medication. Patients with impaired liver function, certain heart valve disorders, gastrointestinal diseases, reduced kidney function, the elderly, etc., should use this medication with caution. Common side effects such as dizziness or swelling may occur during the use of this medication, and rare but serious side effects have also been reported, so any abnormal symptoms should be immediately discussed with a healthcare provider. Taking this medication during pregnancy can lead to dangerous conditions such as impaired fetal kidney function, skull formation abnormalities, and hypotension; thus, if pregnancy is confirmed, the medication should be discontinued immediately. It is also advisable for breastfeeding women to avoid using this medication, and consultation with a specialist is necessary before use. This medication may interact with other drugs, and caution is required when used with lithium, digoxin, warfarin, non-steroidal anti-inflammatory drugs, etc. Symptoms of hypotension may occur, so if symptoms develop, the patient should be lying down and intravenous fluids may be administered as necessary. Caution should be exercised when driving or operating machinery due to possible dizziness or drowsiness. In cases of overdose, severe hypotension and cardiac issues may occur, requiring immediate emergency treatment and following medical advice for appropriate management. Store out of reach of children, keep the product in its original packaging, and open the packaging immediately before use.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbances
  • tremors
  • extrapyramidal symptoms
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disorders
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light in. Additionally, it is important to maintain a room temperature, specifically between 1 degree and 30 degrees Celsius, while storing the medication to safely preserve its efficacy.

Appearance and packaging

Appearance

White and light blue, double convex oval-shaped tablet

Package unit

30 tablets/box [10 tablets/strip × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.